Risk-Based Management of Patients with Cardiac Implantable Electronic Devices Underwent Radiation Therapy: A Practical Review
Year: 2026
Type: article
Abstract: This review summarizes current guidelines and clinical evidence on risk-based management of patients with cardiac implantable electronic devices (CIEDs) undergoing radiation therapy, concentrating on radiation-related device effects, dose assessment, beam quality, and workflow. This narrative review used Task Group 203 of the American Association of Physicists in Medicine guidelines, the 2025 Institute of Physics and Engineering in Medicine/Radiotherapy Board guidance, and relevant European recommendations, together with peer-reviewed studies, particularly from 2020 onward. Key terms included pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization therapy devices, implantable loop recorders, leadless pacemakers, device malfunction, radiation dose, neutron effects, and in vivo dosimetry. The review examined device characteristics, radiation-related malfunctions, major risk factors, and management recommendations. Contemporary evidence indicates that CIED malfunction during radiation therapy is uncommon but clinically relevant in pacing-dependent patients and those with implantable cardioverter-defibrillators. Current guidelines recommend risk stratification based on estimated device dose, pacing dependency, device type, treatment site, and beam quality, with device-dose thresholds of approximately 2 or 5 Gy depending on the guideline or institutional protocol. However, malfunction risk is not determined by cumulative device dose alone. Beam quality and neutron production, particularly with high-energy photon beams and particle therapy, are identified as major risk factors and may warrant high-risk management even with low device dose. Reported abnormalities are often transient or nonsevere, such as reset, oversensing, and parameter changes; however, clinically silent events may be detected more often with intensive device interrogation. Safe management requires early device identification, individualized risk stratification, treatment planning to minimize exposure, selective in vivo dosimetry when dose uncertainty is substantial, and risk-adapted monitoring. Management of patients with CIEDs undergoing radiation therapy should move beyond dose-threshold–based assessment alone incorporate device type, pacing dependency, beam energy, neutron-producing potential, and treatment geometry. A standardized, multidisciplinary, risk-adapted workflow may facilitate safe treatment delivery while avoiding unnecessary treatment interruptions or excessive monitoring in low-risk patients.
Source: Progress in Medical Physics
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7213985463
